Klaus Fink
MerLion Pharma (Germany)(DE)Fraunhofer Institute for Casting, Composite and Processing Technology IGCV(DE)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Ion channel regulation and function, Neurotransmitter Receptor Influence on Behavior, Receptor Mechanisms and Signaling, Nicotinic Acetylcholine Receptors Study
Most-Cited Works
- → Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease(2000)1,048 cited
- → Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia(1998)892 cited
- → Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage(1997)834 cited
- → Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex(2002)492 cited
- → 5-HT Receptor Regulation of Neurotransmitter Release(2007)369 cited
- → Expression of a Dominant Negative Mutant of Interleukin-1β Converting Enzyme in Transgenic Mice Prevents Neuronal Cell Death Induced by Trophic Factor Withdrawal and Ischemic Brain Injury(1997)350 cited